The fertility and pregnancy rapid test kit market size was valued at USD 948.3 million in 2022. By the end of 2023, the industry is likely to reach a valuation of USD 990.4 million. During the forecast period, the industry for fertility and pregnancy rapid test kit is expected to garner a 5% CAGR and reach USD 1,609.1 million by 2033.
Key Industry Trends and Highlights
| Attributes | Details |
|---|---|
| Estimated Market Value in 2022 | USD 948.3 million |
| Expected Market Value in 2023 | USD 990.4 million |
| Expected Market Value in 2033 | USD 1,609.1 million |
| Value-based CAGR from 2023 to 2033 | 5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The fertility and pregnancy rapid test kit market expanded at a 4% CAGR during the historical period.
| Report Attributes | Details |
|---|---|
| Market value in 2018 | USD 810.1 million |
| Market value in 2022 | USD 948.3 million |
| CAGR from 2018 to 2022 | 4% |
The increased rate of infertility is one of the key factors propelling the growth of the global industry for fertility and pregnancy rapid test kit over the projected time frame. For example, in August 2021, the National Survey of Family Growth found that the percentage of infertile women in the 15-34 age group ranged from 7.3% to 9.1%.
The incidence of infertility among women aged 35 to 39 rose to 25%. There was a 30% likelihood of infertility for women between the ages of 40 and 44. Increasing infertility rates as such are boosting the global demand for fertility and pregnancy rapid test kit.
The growing awareness about family planning also rose during the historical period. This pandemic has increased awareness regarding the significance of reproductive health since many couples delayed having children for personal or medical reasons. Factors like these propelled the growth in the industry from 2018 to 2022.
Principal Consultant
The table below lists the top five nations projected to experience significant growth during the forecast period. The United States and China are predicted to have the maximum development among these nations.
Forecast CAGRs from 2023 to 2033
| Countries | CAGR from 2023 to 2033 |
|---|---|
| The United States | 5.2% |
| China | 6% |
| France | 4.1% |
| Japan | 4.7% |
| The United Kingdom | 4.9% |
The fertility and pregnancy rapid test kit market in the United States is expected to garner a 5.2% CAGR during the forecast period.
The United States confronts issues with healthcare affordability and accessibility, and a large number of people are looking for low-cost methods of managing their reproductive health. An easy and cost-effective way to keep track of fertility and pregnancy status is by using an at-home fertility and pregnancy rapid test kit.
Demand for rapid test kit has surged in the United States due to delayed family planning and shifting demographic patterns. These test kits assist people in making educated decisions on having children as numerous people prioritize their education and employment.
The market in China for fertility and pregnancy rapid test kit is likely to expand with a 6% CAGR from 2023 to 2033.
The former one-child restriction and the sizable population of China have led to a high demand for fertility and pregnancy rapid test kit. Interest in these kits has risen due to the one-child ban being loosened and family planning has become increasingly important.
In China, rapid urbanization, lifestyle changes, and several women joining the service sector have contributed to postponed motherhood. The market for these test kits is expanding due to the increasing need for family planning and fertility monitoring.
The fertility and pregnancy rapid test kit market in France is likely to garner a 4.1% CAGR from 2023 to 2033.
Healthcare consumerism and personal responsibility are equally highly valued. This promotes self-management of reproductive health by providing fertility and pregnancy test kit that people may use at home.
Personal privacy is highly valued in French society, especially regarding health issues. The discrete method that at-home test kits provide for tracking fertility and pregnancy in individuals and couples aligns with cultural norms and propels market expansion.
The fertility and pregnancy rapid test kit market in Japan is estimated to accelerate with a 4.7% CAGR during the forecast period.
Japan is experiencing a high than average rate of fertility issues along with delayed family planning. To assist people in managing their reproductive health, there is an increasing need for fertility and pregnancy rapid test kit.
Japan is renowned for its technical ingenuity and the healthcare industry is no exception. Manufacturers in Japan have produced sophisticated and precise pregnancy and fertility test kits, drawing in customers searching for dependable and superior products.
The United Kingdom fertility and pregnancy rapid test kit market is poised to expand with a 4.9% CAGR during the forecast period.
There are issues with the National Health Service in the United Kingdom, including overcrowding and long waiting times for medical attention. People are turning to at-home fertility and pregnancy test kit to keep an eye on their reproductive health quickly and conveniently.
In the United Kingdom, education about sexual and reproductive health is highly valued. People are now conscious of their reproductive health due to this educational focus. In turn, it has raised demand for fertility and pregnancy test kit to aid with family planning decisions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below highlights how the pregnancy rapid test kit is projected to lead the global industry by product type. This segment is expected to develop at a 4.6% CAGR during the forecast period.
The hCG urine test used for pregnancy detection has gained immense traction in the last few years. During the forecast period, the hCG urine test segment is likely to expand with a 4.2% CAGR.
| Category | CAGR from 2023 to 2033 |
|---|---|
| Pregnancy Rapid Test Kit by Product | 4.5% |
| hCG Urine Test by Test Type | 6.2% |
The pregnancy rapid test kit is anticipated to expand at a 4.5% CAGR during the forecast period. A rapid pregnancy test kit is an affordable way to track fertility and is used for family planning.
A rapid pregnancy test kit is accessible to a broad spectrum of people, including those with little financial means, because it is less expensive than clinical testing and seeing a doctor. Thanks to this cost-effective kit, people are empowered to take charge of their reproductive well-being and make sensible choices regarding family planning.
Pregnancy can be identified with several rapid test kit as early as a few days before the next menstruation cycle. Early pregnancy identification makes it possible for people to make informed decisions regarding prenatal treatment and lifestyle modifications at an early stage of the pregnancy.
Based on the test type, the hCG segment is anticipated to take up a significant global market share. The hCG test segment is likely to experience a 6.2% CAGR during the forecast period.
Pregnancy can be identified early on using hCG testing. Susceptible tests can detect hCG levels in blood or urine as early as a few days post-conception, frequently before irregular menstruation. Thanks to this early discovery, people can obtain timely prenatal treatment and make the required lifestyle modifications.
The hCG tests are also used clinically to monitor specific medical problems where excessive hCG levels may be a sign of concern. Given its adaptability, hCG tests are a useful diagnostic tool for obstetrics and other medical fields.
Developing consumer knowledge and preference for certain fertility and pregnancy test kit requires effective marketing and branding initiatives. Manufacturers spend money on advertising campaigns, social media marketing, and collaborations with medical experts to build trust and brand awareness. They could also provide discounts and promotions to promote product adoption and boost revenue and sales.
Prominent Developments by the Key Companies in the Market
| Company | Key Developments |
|---|---|
| Salignostics |
|
| Mankind Pharma |
|
| Mylab Discovery Solutions |
|
| Attributes | Details |
|---|---|
| Projected market value in 2023 | USD 990.4 million |
| Projected market value in 2033 | USD 1,609.1 million |
| Forecast CAGR from 2023 to 2033 | 5% |
| Forecast period | 2023 to 2033 |
| Historical period | 2018 to 2022 |
| Market analysis | Value in USD million |
| Key regions covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa |
| Key countries profiled | The United States, Canada, Brazil, Mexico, Germany, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
| Key market segments | Product, Test Type, Distribution channel, Region |
| Key companies profiled | Alere Inc.; Quidel Corporation; Prestige Brands Holdings, Inc.; Church & Dwight Co., Inc.; bioMérieux SA; Geratherm Medical AG; Abbott Laboratories; Procter & Gamble Co.; DCC Plc.; Swiss Precision Diagnostics GmbH |
Sales of fertility and pregnancy rapid test kit are expected to reach USD 990.4 million by 2023.
By 2033, the fertility and pregnancy rapid test kit market is poised to rise at a 5% CAGR
The fertility and pregnancy rapid test kit market is forecast to reach USD 1,609.1 million by 2033.
The pregnancy rapid test kit is projected to expand at a CAGR of 4.5% during the forecast period.
The hCG test category is anticipated to develop at a 6.2% CAGR through 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Pregnancy Rapid Tests 5.1.1. Line-Indicator devices 5.1.2. Digital 5.2. Fertility Rapid Tests 5.2.1. Line-Indicator 5.2.2. Digital 6. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Test Type 6.1. LH Urine 6.2. FSH Urine 6.3. hCG Blood 6.4. hCG Urine 7. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Distribution channel 7.1. Pharmacy 7.2. Drugstore 7.3. Gynecology/Fertility Clinics 7.4. e-commerce 7.5. Hypermarkets & Supermarkets 8. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market 17. Market Structure Analysis 18. Competition Analysis 18.1. Alere Inc. 18.2. Quidel Corporation 18.3. Prestige Brands Holdings, Inc. 18.4. Church & Dwight Co., Inc. 18.5. bioMérieux SA 18.6. Geratherm Medical AG 18.7. Abbott Laboratories 18.8. Procter & Gamble Co. 18.9. DCC Plc. 18.10. Swiss Precision Diagnostics GmbH 19. Assumptions & Acronyms Used 20. Research Methodology
Healthcare
June 2023
REP-GB-6108
342 pages
Explore Healthcare Insights
View Reports
Fertility and Pregnancy Rapid Test Kit Market
